Poncelet; Alain Philippe

Patent Applications and Registrations

Patent applications and USPTO patent grants for Poncelet; Alain Philippe.The latest application filed is for "benzocycloheptane and benzoxepine derivatives".

Company Profile

0.17.12

Poncelet; Alain Philippe - La Manoir sur Seine FR
Poncelet; Alain Philippe - Le Manoir sur Seine FR
Poncelet; Alain Philippe - Le Manoir FR
Poncelet; Alain Philippe - Issy-les-Moulineaux FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Benzocycloheptane and benzoxepine derivatives Grant 9,040,725 - Schoentjes , et al. May 26, 2	2015-05-26
Substituted phenylenediamines as inhibitors of the interaction between MDM2 and P53 Grant 8,853,406 - Poncelet , et al. October 7, 2	2014-10-07
Benzocycloheptane And Benzoxepine Derivatives App 20140187557 - Schoentjes; Bruno ; et al.	2014-07-03
Benzocycloheptane and benzoxepine derivatives Grant 8,703,973 - Schoentjes , et al. April 22, 2	2014-04-22
Diaza-spiro-{4,4}-nonane derivatives as neurokinin (NK.sub.1) antagonists Grant 8,604,200 - Janssens , et al. December 10, 2	2013-12-10
Cyclic-alkylamine derivatives as inhibitors of the interaction between MDM2 and P53 Grant 8,377,961 - Lacrampe , et al. February 19, 2	2013-02-19
Benzocycloheptane And Benzoxepine Derivatives App 20120322796 - SCHOENTJES; Bruno ; et al.	2012-12-20
Benzocycloheptane and benzoxepine derivatives Grant 8,278,466 - Schoentjes , et al. October 2, 2	2012-10-02
Inhibitors of the interaction between MDM2 and P53 Grant 8,232,298 - Lacrampe , et al. July 31, 2	2012-07-31
Cyclic-alkylamine Derivatives As Inhibitors Of The Interaction Between Mdm2 And P53 App 20120071508 - Lacrampe; Jean Fernand Armand ; et al.	2012-03-22
Substituted oxa-diaza-spiro-[5.5]-undecanone derivatives and their use as neurokinin antagonists Grant 8,138,334 - Jenssens , et al. March 20, 2	2012-03-20
Cyclic-alkylamine derivatives as inhibitors of the interaction between MDM2 and p53 Grant 8,088,795 - Lacrampe , et al. January 3, 2	2012-01-03
Substituted Phenylenediamines As Inhibitors Of The Interaction Between Mdm2 And P53 App 20110130418 - Poncelet; Alain Philippe ; et al.	2011-06-02
Benzocycloheptane And Benzoxepine Derivatives App 20110046139 - Schoentjes; Bruno ; et al.	2011-02-24
Substituted Oxa-diaza-spiro-[5.5]-undecanone Derivatives And Their Use As Neurokinin Antagonists App 20100292228 - Jenssens; Frans Eduard ; et al.	2010-11-18
Cyclic-alkylamine Derivatives As Inhibitors Of The Interaction Between Mdm2 And P53 App 20100168163 - Lacrampe; Jean Fernand Armand ; et al.	2010-07-01
Metabotropic glutamate receptor antagonists Grant 7,629,468 - Mabire , et al. December 8, 2	2009-12-08
Substituted diaza-spiro-[4.5]-decane derivatives and their use as neurokinin antagonists Grant 7,612,056 - Janssens , et al. November 3, 2	2009-11-03
Inhibitors Of The Interaction Between Mdm2 And P53 App 20090149493 - Lacrampe; Jean Fernand Armand ; et al.	2009-06-11
Substituted diaza-spiro-[5.5]-undecane derivatives and their use as neurokinin antagonists Grant 7,544,694 - Janssens , et al. June 9, 2	2009-06-09
Substituted Diaza-Spiro-[4.5]-Decane Derivatives and Their Use as Neurokinin Antagonists App 20070254904 - Janssens; Frans Eduard ; et al.	2007-11-01
Substituted Diaza-Spiro-[5.5]-Undecane Derivaties and Their Use as Neurokinin Antagonists App 20070232636 - Janssens; Frans Eduard ; et al.	2007-10-04
Metabotropic glutamate receptor antagonists Grant 7,115,630 - Mabire , et al. October 3, 2	2006-10-03
Metabotropic glutamate receptor antagonists App 20050209273 - Mabire, Dominique Jean-Pierre ; et al.	2005-09-22
Metabotropic glutamate receptor antagonists App 20040082592 - Mabire, Dominique Jean-Pierre ; et al.	2004-04-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.